Refex Industries Q4 PAT Doubles to 94 Crore FY26 Profit Reaches 204 Crore Bernstein Initiates Coverage of Neurocrine Biosciences With Outperform Rating 221 Target Kevin Warsh Poised for Fed Role Amid Internal Struggle Over Rate Cut Path US Productivity Growth Slows in Q4 as Unit Labor Costs Accelerate Data Shows Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Regulatory Barriers Inflation Pressures Broaden Sectors Beyond Energy and Geopolitics Show Price Reacceleration UPWK Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction CNXC Q1 2026 Earnings EPS Misses Estimates Amid Market Challenges Stock Rises PERI Q1 2026 Earnings Strong Profitability Beat Drives Stock Gains STEX Q1 2026 Earnings Major EPS Miss but Stock Surges on Optimism WW Q1 2026 Earnings Sharp EPS Miss Overshadowed by 2676 Stock Surge PRTS Q1 2026 Earnings EPS Surprises to the Upside Revenue Details Not Disclosed